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Endothelin (ET-l) has been shown to exert vasoconstrictor activity in vivo and mobilize Caz+ in vascular smooth muscle 
cells in culture. In this paper we show that the human skin fibroblast exhibits specific receptors to ET-I and that activation 
of these receptors results in increased intracellular Ca 2+ 
Ca:+ in a dose-response manner; the peak Cat+ 
(Ca:‘) and accelerated Nat/H+ antiport activity. ET-l raised 
rise was from basal levels of 112.2 k 21.9 to 299.2 + 49.7 nM at 300 
nM ET-I. This rise was attenuated by removal of extracellular Ca:+O. Although ET-l did not alter basal intracellular 
pH, it enhanced Na+/H+ antiport activity of acidified cells. Fibroblasts demonstrated 156 & 18 (mean f SE) ET-I re- 
ceptors per unit cell and an equilibrium dissociation constant of 203.4 & 35.6 pM. Inasmuch as ET-I plays a role in 
the metabolism of cells such as the undifferentiated fibroblast, an important action of this peptide may be to act as a 
growth factor. 
Endothelin; Growth factor; (Human skin fibroblast) 
1. INTRODUCTION 
Endothelin-1 (ET-l), a peptide derived from en- 
dothelium [ 11, affects different cells including 
vascular smooth muscle cells (VSMC) [l-5], 
mesangial cells [6], atria1 myocytes [7] and jux- 
taglomerular cells [8]. ET-l increases intracellular 
Ca2+ (Caf’) in cultured VSMC and has 
vasoconstrictor effects in vascular beds and 
isolated arterial segments [1-5,9-l 11. ET-l 
mediated increases in Ca?’ may result from activa- 
tion of voltage-sensitive Ca2+ channels, as many of 
the observed responses are dihydropyridine- 
sensitive and dependent on extracellular Ca2+ 
[1,3,10,11]. However, in VSMC ET-l also in- 
creases inositol phosphates in concert with a rise in 
Car” [2,5,12,13], indicating Ca2+ mobilization 
from intracellular stores. 
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Only recently has it been appreciated that several 
vasoconstrictors can act as growth factors for 
VSMC [14,15]. These include ET-l, which 
stimulates VSMC proliferation, DNA synthesis, 
and the induction of c-fos and c-myc mRNAs 
[3,4]. Since ET-l elicits growth-related responses 
in VSMCs, we investigated its action in an undif- 
ferentiated cell, the human skin fibroblast. We 
first examined whether fibroblasts could respond 
to ET-l by mobilizing Ca2+ and activating 
Na+/H+ antiport activity. These two intracellular 
responses are associated with increased growth 
[16,17]. Second, we explored whether these cells 
contained receptors specific for the ET-l peptide. 
2. MATERIALS AND METHODS 
2.1. Materials 
Synthetic ET-l was from Cambridge Biochemicals (Valley 
Stream, NY), and “‘I-ET-1 from Peninsula Laboratories (Bel- 
mont, CA). Fura 2-AM and BCECF-AM were from Molecular 
Probes (Eugene, OR). All other chemicals and ionophores were 
from Sigma (St. Louis, MO). 
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2.2. Cell culture 
Human fibroblasts, derived from arm biopsies (2 x 3 mm) of 
13 volunteers, were processed as previously described [18]. Cells 
were grown in Dulbecco’s modified Eagle’s medium (DMEM; 
95% air, 5% COz with 10% fetal bovine serum (FBS, Gibco), 
2 mM L-glutamine, 50pg/ml streptomycin and 50 U/ml 
penicillin). Cells (passages 6-l 1) were inoculated 3-4 days prior 
to experiments on 13.8 x 30 mm glass coverslips in Nunc 6-well 
plates for subsequent Ca? and pHi measurements. Binding ex- 
periments were performed on cells grown directly in the Nunc 
6-well plates. Cells were grown as above (minus antibiotics) un- 
til confluent, and were made quiescent by a 24 h FBS depletion. 
No effects of passage number, or gender or age of donor were 
observed on the various cell parameters. 
2.3. Measurement of Ca? 
Coverslips (containing 3-7 x lo5 cells) were incubated with 
5 pM fura 2-AM in 2 ml (37°C) of Hepes-buffered solution 
(HBS) containing (in mM): 140 NaCl, 5 KCI, 2 CaClz, 1 MgClz, 
10 Hepes, 10 glucose and 0.1% BSA (fraction V), pH 7.35. 
Cells were exposed to the dye for 60 min, after which they were 
washed 3 times with HBS and secured in a quartz cuvette in a 
SPEX CM3 fluorescence spectrometer (equipped with a ther- 
mostatically controlled (37°C) cell holder, stirrer, and suction 
device for removing solutions). Excitation wavelengths were set 
at 340 and 380 nm and emission wavelength at 505 nm. Cells 
were preincubated l-3 min until signal stabilized; at the end of 
the experiment autofluorescence was determined for each 
coverslip (by subjecting cells to 2 mM Mn*+ and 1OpM 
ionomycin for 5 min) and subtracted from the fluorescent 
signal. Calculations of R,,,, Rmin and S&&2 for Ca*+ calibra- 
tion [19] were performed on similarly prepared coverslips by ex- 
posing cells to 3 mM EGTA, 10gM ionomycin (without and 
with 0.1% BSA), and 5 mM Ca*+, 10 pM ionomycin (without 
and with 0.1% BSA). 
2.4. Measurement of cytosolic PHi 
Coverslips were incubated with 5 pM BCECF-AM at 37°C in 
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HBS for 40 min. After 3 washes in HBS, they were placed in the 
SPEX (excitation wavelengths 440 and 503 nm and emission 
wavelength 530 nm) and monitored for 5-7 min until pHi 
stabilized. Calibration of pHi was performed by subjecting cells 
to 5 yg/ml nigericin in HBS (minus BSA) at pH values ranging 
between 6.30 and 7.50 and a K+ of 140 mM (KC1 substituted 
isosmotically for NaCl) [20]. Na+/H+ antiport activity was 
assessed after acidification of cells with an NH&Z1 prepulse, by 
measuring the Na+-dependent recovery in pHi during the initial 
lo-30 s of pHi change. This pHi recovery is inhibited by the 
amiloride analog 5-(N-methyl-N-isobutyl)amiloride, indicating 
that the Na+/H’ antiport is activated by cellular acidification 
in nominally bicarbonate free medium (data not shown). HBS 
solutions in which the (Na+] was less than 140 mM contained 
N-methyl-D-glucamine substituted isosmotically for NaC. 
2.5. 12’I-ET-I binding to fibroblasts 
‘251-ET-1 binding was performed by incubating fibroblasts 
for 90 min at 22°C in 1 ml of phosphate-buffered saline (PBS). 
Binding medium contained 44.4 pM ‘251-ET-l (spec. act. = 
1200 Ci/mmol), 0.2% BSA, 100 KU/ml aprotinin and varying 
concentrations (O-l .2 nM) of unlabeled ET-l. In preliminary 
experiments, binding of ET-l reached a plateau phase within 
60 min and remained stable for at least 120 min. Thereafter, the 
medium was aspirated and cells were washed 5 times with 2 ml 
ice-cold PBS. Cells were extracted with 5% trichloroacetic acid 
and ‘*?-radioactivity was measured in a gamma counter. Total 
binding averaged 0.21 + 0.03% of total activity added to each 
well. Nonspecific binding (60.0 + 4.5% of total binding) was 
determined in the presence of excess (400 nM) unlabeled ET-l. 
Cell number was determined by a Coulter counter and averaged 
1 147970 + 8470 cells/well. 
2.6. Data analysis 
Data are presented as means + SE, with n equal to the 
number of individuals studied. Where noted, statistical com- 
parisons were made using the paired Student’s t-test. 
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Fig.1. (A-C) Caf’ profiles elicited by increasing doses of ET-l (arrows). Closed symbols ([Ca*‘], = 1.8 mM) and open symbols 
(]Ca% < 1 nM) represent he [Ca*+]i of 5 individuals responding to ET-l. ET-l (10 nM) failed to increase [Ca*+]i in cells exposed 
to Ca*+ free medium. 
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Fig.2. (A-C) Effects of ET-l on pHi (A) and Na+-dependent pHi recovery in acidified fibroblasts (B and C). 100 nM ET-l (arrow) 
was added to cells at rest or after acidification by NHdCI prepulse. (B) The NH&Z1 prepulse procedure is illustrated and the effect of 
ET-l on the alkalinization response is shown. Recovery solutions contained 140 mM Na+. In control experiments (not shown), the 
pHi values for Na+-dependent recoveries were not different after two consecutive acidifications by the NH.+CI prepulse method 
(0.027 f 0.004 and 0.026 k 0.007 pHi units/l0 s, respectively, n = 5). (C)Cells were acidified as illustrated in B, and exposed to 40 mM 
or 140 mM Na+-containing HBS, without and with 100 nM ET-l (n = 7, * p = 0.020, ** p = 0.003). 
3. RESULTS 
Fig.1 shows averaged Cat’ transients in 
fibroblasts from 5 individuals responding to ET-l. 
In Caf’ containing media, the threshold for in- 
creases in Ca?’ occurred at l-3 nM and maximum 
Ca? responses were observed at 300 nM ET-l. 
Peak [Ca2+]i at 15 s after exposure to ET-l were 
significantly greater when measured in the 
presence of extracellular Ca2+ than in Ca2+ free 
medium (containing 1 mM EGTA) (282.0 f 34.6 
vs 161.3 + 67.5 nM at 100 nM ET-l and 299.2 + 
49.7 vs 170 f 23.7 nM at 300 nM ET-l, respective- 
ly, n = 5, p c 0.05). In fibroblasts from 7 other in- 
dividuals, ET-l elicited no measurable response in 
Ca2+ free or Ca2+-containing media. The reason 
for this lack of response was not apparent. 
Agonist-mediated Cat’ signalling is frequently 
coupled with activation of the Na+/H+ antiport. 
Moreover, mitogenesis and the action of growth 
40 
factors are commonly associated with stimulation 
of the Na+/H+ antiport in several cell types, in- 
cluding fibroblasts [14-161. We measured the ef- 
fect of ET-l on pHi and Nat/H+ antiport activity 
in human fibroblasts (fig.2). ET-l added to cells 
under basal conditions (pHi = 7.23 f 0.05) exerted 
no change in pHi over a 10 min interval (pHi at 
10 min = 7.23 + 0.05, n = 5, fig.2A). However, in 
cells acidified by the NH4Cl prepulse method, 
100 nM ET-l significantly increased the rate of 
Na+-dependent alkalinization by 1.7-fold 
(fig.2B,C). These effects were demonstrated in 6 of 
7 individuals studied. 
1251-ET-1 binding to fibroblasts showed 
saturable binding. The displacement of labeled 
ET-l by the unlabeled peptide (fig.3) indicated a 
B,,, value of 156 f 18 binding sites/cell and a Kd 
value of 203.4 f 35.6 pM. The Hill coefficient was 
0.99, indicating no evidence of cooperativity in 
ET-l binding to fibroblasts. 
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Fig.3. Displacement of ‘251-ET-l from specific receptors by 
unlabeled ET-l. The curve depicts the fit of the model, 
described by eqn. 1, to the data, 
B = &,,,,fL/& x (1 + (i/&)r + L] (1) 
where B is the specific ET-l binding, R,, is the m~imum 
specific binding, & is the equilibrium dissociation constant, Z, 
is the concentration of ‘*%ET-1, i is the concentration of 
unlabeled ET-I, and N is the Hill coefficient. Nonlinear 
regression analysis of ET-l binding was performed on an IBM 
compatible personal computer using an NLIN regression 
procedure of SAS [22]. 
4. DISCUSSION 
Specific receptors for ET-1 have been 
demonstrated in cultured human VSMCs [5,12] 
and cultured myometrial cells (Maher, E. and 
Aviv, A., unpublished data). We report that 
human skin fibroblasts which respond to ET-l do 
so in a dose-response manner with a partial 
dependence on extracellular Cat’. These cells also 
exhibit ET-l-dependent changes+n pHi when sub- 
jected to an acid load. Finally, human fibroblasts 
exhibit high-affinity receptors specific to ET-l. 
These findings suggest ET-l related Ca?’ tran- 
sients and activation of the Na+/H+ antiport are 
receptor mediated, possibly occurring through the 
phosphoinositide and diacylglycero1 signaling 
systems as shown in other cells [2,6]. 
The Cai” transients following ET-l addition to 
monolayers were similar to VSMCs and other cells 
[2,6,9,101, with respect to their dose-response 
curves and extracellular Ca2’ dependency. 
Although a number of preparations failed to show 
an increase in Ca2+ in response to ET-I, specific 
‘251-binding to cells was readily demonstrated in all 
preparations studied. These observations suggest 
that the lack of the Ca2+ response in these cells is 
at a level distal to the receptor-ligand interaction. 
There are few reports on ET-1 activation of the 
Na+/H’ antiport. In work with cultured mesangial 
cells, Badr et al. [6] reported that endothelin in- 
creased pHi from basal values (pHi = 6.79) to a 
pHi of 7.27. We observed no change in resting pHi 
with 100 nM ET-l. This difference may be due to 
the lower basal pHi in mesangial cells. Thar is, 
ET-l may have shifted the pHi dependence of the 
antiporter in mesangial cells to an alkaline pHi 
value that resulted in stimulation of Na+/H’ ex- 
change and cellular alkalinization. It has previous- 
ly been demonstrated that serum and specific 
growth factors activate the Na+/H+ antiport by in- 
creasing the H” affinity of this transport process 
[22-241. In cultured fibroblasts, the resting pHi ex- 
hibited by these cells may have been too alkaline, 
such that activation of the antiport could only be 
demonstrated following intracellular acidification. 
Thus, the mechanism of ET-I stimulation of the 
Na+/H+ antiport may be similar to that suggested 
for phorbol esters, hormones and growth factors 
that activate phosphoinositide hydrolysis [25]. 
The presence of specific ET-l receptors in 
human skin fibroblasts and their coupling with 
Cat’ signalling and the Na+/H+ antiport suggest a 
metabolic role for ET-l. Recently, Takuwa et al. 
[26] reported that endothelin transiently increased 
C-$X and c-myc protooncogenes in Swiss 3T3 cells 
via activation of protein kinase C-dependent 
mechanisms. We propose that ET-1 acts as a 
growth factor for fibroblasts and other, more 
specialized cells possessing ET-l receptors. 
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